Submitted by drupal on Sat, 10/27/2012 - 5:00pm NCT00749216 Solanezumab United States Monday, September 1, 2008 – Friday, July 31, 2009 33 Phase 2 Alzheimer's Disease Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by drupal on
Submitted by drupal on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.